Business Context and Reporting Period
LeMaitre Vascular, Inc. filed this Form 8-K on September 14, 2009, reporting the entry into a material definitive agreement. The filing addresses an amendment to the company's existing revolving loan facility with Brown Brothers Harriman & Co.
Key Financial Metrics
- Debt Facility: The amended agreement maintains a borrowing capacity of up to $10 million in the aggregate, including a sub-limit of $3 million for letters of credit.
- Interest Rate: Loans bear interest at LIBOR plus 200 basis points or the Bank's base rate, at the Company's discretion.
- Commitment Fee: The amendment requires an annual commitment fee of 0.30% of the $10 million commitment amount.
- Outstanding Borrowings: As of the filing date, the Company has no borrowings outstanding under the Loan Agreement.
- Covenant Compliance: The Company was in compliance with all financial and operating covenants as of June 30, 2009.
Material Changes Versus Prior Period
The primary change involves the extension of the Loan Agreement's maturity date. Previously, the term was set to expire on August 23, 2009, after the Bank indicated in June 2009 that it would not renew the facility under existing terms. The new Letter Agreement extends the maturity date to August 23, 2011. Additionally, the agreement introduces a new annual commitment fee and modifies a financial covenant related to the leverage test calculation.
Outlook, Risks, and Management Commentary
The extension of the credit facility secures the Company's liquidity options for the next two years. The filing notes that the first commitment fee was due upon execution of the Letter Agreement, and the Company intends to pay this amount immediately. The agreement continues to require the Company to meet specific financial and operating covenants, with borrowings secured by substantially all of the Company's assets.
Key Facts for Investor Verification
- Verify the specific details of the modified leverage test covenant to understand future financial constraints.
- Confirm the immediate cash outflow associated with the first annual commitment fee payment.
- Monitor future compliance with the financial covenants to ensure the facility remains available.
- Note that while the facility is extended, the Company currently holds no outstanding debt under this agreement.